WO2001050132A3 - Procede de detection de modifications de la prostate chez des chiens - Google Patents

Procede de detection de modifications de la prostate chez des chiens Download PDF

Info

Publication number
WO2001050132A3
WO2001050132A3 PCT/AT2001/000001 AT0100001W WO0150132A3 WO 2001050132 A3 WO2001050132 A3 WO 2001050132A3 AT 0100001 W AT0100001 W AT 0100001W WO 0150132 A3 WO0150132 A3 WO 0150132A3
Authority
WO
WIPO (PCT)
Prior art keywords
prostate
psp
dogs
sample
changes
Prior art date
Application number
PCT/AT2001/000001
Other languages
German (de)
English (en)
Other versions
WO2001050132A2 (fr
Inventor
Manfred Gemeiner
Monika Teinfalt
Original Assignee
Innovationsagentur Gmbh
Manfred Gemeiner
Monika Teinfalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovationsagentur Gmbh, Manfred Gemeiner, Monika Teinfalt filed Critical Innovationsagentur Gmbh
Priority to AU26516/01A priority Critical patent/AU2651601A/en
Publication of WO2001050132A2 publication Critical patent/WO2001050132A2/fr
Publication of WO2001050132A3 publication Critical patent/WO2001050132A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/342—Prostate diseases, e.g. BPH, prostatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne un procédé de détection de modifications de la prostate chez des chiens, caractérisé par les étapes suivantes : prélèvement d'urine, détermination du taux d'antigène spécifique de la prostate (ASP) dans ledit prélèvement, et comparaison du taux d'ASP ainsi déterminé avec au moins un taux d'ASP de référence. L'invention concerne également un kit de mise en oeuvre de ce procédé.
PCT/AT2001/000001 2000-01-04 2001-01-03 Procede de detection de modifications de la prostate chez des chiens WO2001050132A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU26516/01A AU2651601A (en) 2000-01-04 2001-01-03 Method for detecting changes in the prostate of dogs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT52000A AT409192B (de) 2000-01-04 2000-01-04 Verfahren zur detektion von veränderungen in der prostata von rüden
ATA5/2000 2000-01-04

Publications (2)

Publication Number Publication Date
WO2001050132A2 WO2001050132A2 (fr) 2001-07-12
WO2001050132A3 true WO2001050132A3 (fr) 2002-04-18

Family

ID=3492777

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT2001/000001 WO2001050132A2 (fr) 2000-01-04 2001-01-03 Procede de detection de modifications de la prostate chez des chiens

Country Status (3)

Country Link
AT (1) AT409192B (fr)
AU (1) AU2651601A (fr)
WO (1) WO2001050132A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2942542B1 (fr) * 2009-02-23 2017-10-06 Vibrac Methode d'analyse permettant le diagnostic in vitro d'une hyperplasie benigne de la prostate chez un chien par dosage de la canine prostate specific esterase, et le suivi du traitement de l'hbp

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BELL F W ET AL: "Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disorders.", JOURNAL OF VETERINARY INTERNAL MEDICINE, (1995 MAY-JUN) 9 (3) 149-53., XP001014409 *
ISAACS W B ET AL: "IMMUNOLOGICAL LOCALIZATION AND QUANTITATION OF THE ANDROGEN-DEPENDENT SECRETORY PROTEASE OF THE CANINE PROSTATE", ENDOCRINOLOGY, vol. 117, no. 4, 1985, pages 1512 - 1520, XP001014777, ISSN: 0013-7227 *
ISAACS W B ET AL: "THE PREDOMINANT PROTEIN OF CANINE SEMINAL PLASMA IS AN ENZYME", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 259, no. 18, 1984, pages 11520 - 11526, XP001014421, ISSN: 0021-9258 *
ISAACS W B: "STRUCTURAL AND FUNCTIONAL COMPONENTS IN NORMAL AND HYPERPLASTIC CANINE PROSTATES", PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH, 1984, pages P307 - 332, XP001014479, ISSN: 0361-7742 *
MATSUDA Y ET AL: "STUDIES ON ACIDIC ARGININE ESTERASE EXCRETED IN URINE 1. PURIFICATION AND CHARACTERIZATION OF DOG URINARY ARGININE ESTERASE", CHEMICAL & PHARMACEUTICAL BULLETIN (TOKYO), vol. 32, no. 6, 1984, pages 2371 - 2379, XP001010459, ISSN: 0009-2363 *

Also Published As

Publication number Publication date
WO2001050132A2 (fr) 2001-07-12
AT409192B (de) 2002-06-25
AU2651601A (en) 2001-07-16
ATA52000A (de) 2001-10-15

Similar Documents

Publication Publication Date Title
WO1999042839A3 (fr) Traitement du cancer
WO2002077604A3 (fr) Cellules marquees servant de temoin fonctionnel interne dans des essais de detection de cellules rares
CA2320418A1 (fr) Methodes et reactifs pour l'isolation rapide et efficace de cellules cancereuses circulantes
WO2006020579A3 (fr) Procede d'identification rapide de micro-organismes
WO2003043487A3 (fr) Procede d'utilisation d'une proteine non anticorps permettant de detecter et de mesurer un analyte
AU1674400A (en) Kidney disease detection and treatment
EP1381864A4 (fr) Detection du candida
WO2003009100A3 (fr) Methodes, appareil et programmes informatiques de verification de l'integrite d'une sonde
WO2002035232A3 (fr) Methode de detection ddu cancer de l'ovaire
AU2849300A (en) Methods and assay kits for detecting mononuclear cell phenotype
WO2004011607A3 (fr) Reactif et technique de determination d'une substance utilisant un immunoregroupeur
WO2002008461A3 (fr) Methodes d'analyse et d'identification de genes transcrits et empreinte genetique
WO2007063326A3 (fr) Dispositif et procede de dosage
AU2003260457A1 (en) A method and kit for the quantitative and/or qualitative detection of components in a sample
WO2006004958A3 (fr) Detection ou mesure d'anticorps par rapport a proteines antigenes dans des tissus ou des echantillons biologiques
WO2003100006A3 (fr) Methode d'analyse de formes non complexees d'un antigene prostatique specifique dans un echantillon permettant d'ameliorer la detection du cancer de la prostate
CA2407760A1 (fr) Methodes pour le diagnostic de l'astrocytome de bas grade
WO2001050132A3 (fr) Procede de detection de modifications de la prostate chez des chiens
EP1712918A4 (fr) Procede permettant de detecter la thrombose en mesurant l'enzyme clivant le facteur de von willebrand
WO2003100079A3 (fr) Procede d'analyse de formes proenzymatiques d'antigenes specifiques de la prostate dans des serums pour ameliorer la detection du cancer de la prostate
WO2002090989A3 (fr) Procede permettant de detecter des antigenes de globules sanguins et des anticorps diriges contre ces antigenes
WO2001084161A3 (fr) Methode ameliore de mesure de fer non lie a la transferrine
DK1057021T3 (da) Fremgangsmåde til måling af totalanalyt
WO2002048398A3 (fr) Systeme d'hybridation in situ de mise en evidence specifique de micro-organismes
WO2002077285A3 (fr) Procedes de detection de la presence de polynucleotides par amplification

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref country code: AT

Ref document number: 2001 9001

Date of ref document: 20010712

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 20019001

Country of ref document: AT

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP